Atara beats estimates with loss in Q1
Atara Biotherapeutics had a net loss of $78.2 million in the first quarter of fiscal year 2021, slightly higher compared than same quarter a year earlier, when the company had a loss of $73.5 million. Despite this, Atara, an immunotherapy biotech company based in South San Francisco with some of its major operations in Thousand Read More →
Fienup: A long road to get economy out of ‘crisis mode’
Ventura County’s economy was in a rougher place than previously understood when the pandemic started, and rebuilding it in a way that benefits everyone is going to take a lot of careful work. That was the message from Matthew Fienup, the executive director of the Center for Economic Research and Forecasting at California Lutheran University, Read More →
LTC Properties reports income drop
LTC Properties saw its net income drop almost 80% in a year as it missed estimates and saw decreased rental income. The Westlake Village-based real estate investment trust, which specializes in health care and senior living properties, reported $13.6 million in net income, or 35 cents per diluted share, for the first quarter of 2021. Read More →
Thousand Oaks biotech firm closes $140M funding round
Capsida Biotherapeutics, a biotechnology startup based in Thousand Oaks, announced April 29 that it is emerging from “stealth mode” with a $140 million funding round led by Westlake Village BioPartners and Versant Ventures. The Series A round includes $50 million from Westlake Village BioPartners, a venture capital firm in Thousand Oaks focused on biotech startups Read More →
Teledyne shares up on earnings news as Flir acquisition draws nearer
Teledyne Technologies saw growth in nearly all markets during the first quarter of 2021, helping the company beat expectations and deliver positive results on its first earnings report of the year. Teledyne, a Thousand Oaks-based industrial and scientific conglomerate, reported an adjusted earnings per share of $3.02 for the first quarter of 2021, beating Zacks’ Read More →
Amgen stock tumbles after earnings report
Editor’s note: This article was updated at 8:35 a.m. on April 28 with up-to-date information on Amgen’s stock price. Amgen’s shares fell nearly 8% following the company’s April 27 release of its first quarter 2021 earnings, which saw a decline in both revenue and net income compared to a year earlier. Amgen is headquartered in Read More →
PureSpectrum closes $17M funding round
PureSpectrum, an online market research company based in Westlake Village, recently secured $17 million in Series B funding from Arthur Ventures, a Minneapolis-based growth equity firm. The company connects researchers with online survey respondents. It grew out of Hub101, California Lutheran University’s entrepreneurial coworking space, and in the five years since it was created has Read More →
